Federated Hermes Inc. Purchases 129,688 Shares of Bath & Body Works, Inc. $BBWI

Federated Hermes Inc. lifted its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 30.2% in the third quarter, HoldingsChannel reports. The firm owned 559,712 shares of the company’s stock after purchasing an additional 129,688 shares during the quarter. Federated Hermes Inc.’s holdings in Bath & Body Works were worth $14,418,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Stonehage Fleming Financial Services Holdings Ltd purchased a new position in shares of Bath & Body Works in the 2nd quarter worth $33,000. First Horizon Corp purchased a new stake in shares of Bath & Body Works during the 3rd quarter valued at about $29,000. Geneos Wealth Management Inc. grew its position in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares in the last quarter. Parkside Financial Bank & Trust grew its position in Bath & Body Works by 24.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after acquiring an additional 364 shares in the last quarter. Finally, Carolina Wealth Advisors LLC bought a new stake in Bath & Body Works during the third quarter worth approximately $54,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Insider Transactions at Bath & Body Works

In other news, Director Francis Hondal purchased 3,343 shares of the company’s stock in a transaction dated Friday, November 21st. The shares were acquired at an average price of $14.99 per share, with a total value of $50,111.57. Following the transaction, the director owned 21,554 shares of the company’s stock, valued at $323,094.46. This represents a 18.36% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Steven E. Voskuil purchased 20,000 shares of the business’s stock in a transaction dated Friday, November 21st. The shares were purchased at an average price of $15.04 per share, for a total transaction of $300,800.00. Following the purchase, the director owned 33,925 shares of the company’s stock, valued at approximately $510,232. This trade represents a 143.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 33,513 shares of company stock worth $500,442 in the last ninety days. 0.26% of the stock is owned by company insiders.

Bath & Body Works Trading Up 5.1%

NYSE BBWI opened at $21.79 on Friday. The stock has a market cap of $4.46 billion, a PE ratio of 6.70, a PEG ratio of 0.75 and a beta of 1.51. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $41.87. The company’s 50-day moving average price is $20.39 and its 200-day moving average price is $24.72.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). The company had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The company’s quarterly revenue was down 1.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.49 EPS. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. As a group, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Friday, November 21st were issued a $0.20 dividend. The ex-dividend date was Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.7%. Bath & Body Works’s payout ratio is presently 24.62%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on BBWI shares. Zacks Research raised Bath & Body Works from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 20th. JPMorgan Chase & Co. lowered their price target on Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating for the company in a research report on Thursday, November 20th. Telsey Advisory Group lowered shares of Bath & Body Works from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $38.00 to $17.00 in a research note on Friday, November 21st. Barclays increased their target price on shares of Bath & Body Works from $18.00 to $20.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 6th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, January 21st. Five investment analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $23.53.

Key Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

• Neutral Sentiment: Context on recent operating results and analyst commentary — a recent industry roundup revisits Bath & Body Works’ Q3 earnings and may inform investor views on fundamentals rather than litigation. Reflecting on beauty and cosmetics retailer stocks’ Q3 earnings: Bath and Body Works (NYSE:BBWI)
• Negative Sentiment: Multiple securities class actions filed / law firms soliciting plaintiffs — firms (e.g., Gainey McKenna & Egleston, Kessler Topaz, Glancy Prongay Wolke & Rotter and others) say suits were filed on behalf of investors who bought BBWI between June 4, 2024 and Nov 19, 2025, alleging material misstatements/omissions tied to a sharp Nov. 19 share drop. These notices increase litigation risk and could lead to settlements, higher legal costs, management distraction and investor uncertainty. Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bath & Body Works, Inc. (BBWI) Kessler Topaz Meltzer & Check, LLP Encourages Bath & Body Works, Inc. Investors with Losses to Contact the Firm Deadline Alert: Glancy Prongay Wolke & Rotter LLP
• Negative Sentiment: Deadlines and scale — several firms cite lead‑plaintiff filing deadlines in mid‑March (March 13–16, 2026). The breadth of solicitations (many firms contacting investors) suggests sustained media/legal attention, which can prolong volatility and keep a risk premium on the shares until claims are resolved or dismissed. Faruqi & Faruqi, LLP Investigates Claims

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.